Tirzepatide has become one of the most in-demand prescription medications in recent years due to its strong effects on blood sugar control and weight loss. As awareness grows, many people are now searching for ways to get tirzepatide online instead of going through traditional in-person clinics. While online access is convenient and often faster, it also comes with important considerations...

According to a newly published market research report by 24LifeSciences, global Azilsartan market was valued at USD 580 million in 2025 and is projected to reach USD 850 million by 2034, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2034. Azilsartan, an angiotensin II receptor blocker (ARB), is clinically recognized for its selective AT1 subtype...

According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...

According to a new report from Intel Market Research, the global ibuprofen market was valued at USD 87.4 million in 2024 and is projected to grow from USD 89.9 million in 2025 to USD 106 million by 2032, exhibiting a steady CAGR of 2.9% during the forecast period (2025–2032). This growth is driven by the increasing global burden of chronic pain conditions and inflammatory diseases, rapid...

 According to a newly published market research report by 24LifeSciences, global lacidipine market was valued at USD 245.7 million in 2025 and is projected to reach USD 387.4 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 20262034. Lacidipine, clinically classified as a long-acting...

According to a new report from Intel Market Research, the global Over The Counter (OTC) Drugs market was valued at USD 155.1 billion in 2024 and is projected to grow from USD 162.9 billion in 2025 to USD 216.8 billion by 2034, exhibiting a steady CAGR of 5.0% during the forecast period (2025–2034). This growth is driven by increasing consumer preference for self-medication, rising...

According to a newly published market research report by 24LifeSciences, global postoperative nausea and vomiting (PONV) market was valued at USD 1,958 million in 2024 and is projected to reach USD 3,117 million by 2031, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period 2025-2031. Postoperative nausea and vomiting (PONV), a common complication affecting...

Inflammatory bowel disease (IBD) continues to represent a significant healthcare challenge worldwide, with rising prevalence rates and increasing demand for advanced treatment options. The growing focus on patient-centered care, biologic therapies, and digital healthcare solutions is transforming the treatment landscape. Healthcare providers, pharmaceutical companies, and regulatory authorities...

According to the latest report published by Data Bridge Market Research, the Ethical Pharmaceuticals Market  CAGR Value The global ethical pharmaceuticals market size was valued at USD 5.38 billion in 2024 and is expected to reach USD 10.12 billion by 2032, at a CAGR of 8.20% during the forecast period Market insights provided in the most excellent Ethical Pharmaceuticals Market...

According to the latest report published by Data Bridge Market Research, the Cold Sore Treatment Market  CAGR Value The global cold sore treatment market was valued at USD 879.70 million in 2024 and is expected to reach USD 1466.82 million by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.60%, primarily driven by the anticipated launch...